Recent news on Eszopiclone

US PSYCH: Insomnia Treatment Boosts Antidepressant Efficacy  -  Apr 26, 2007
Psychiatric Times,In a study published in the journal Biological Psychiatry in 2006, patients who took both the sleep aid eszopiclone (Lunesta) and fluoxetine (Prozac) had an

Research and Markets: In 2005, Sepracor's New Insomnia Drug ...  -  Apr 27, 2007
PharmaLive.com (press release),In 2005, Sepracor's new insomnia drug Lunesta (eszopiclone) accounted for the greatest single drug investment in DTC advertising, with a total US spend of

US PSYCH: Insomnia Treatment Boosts Antidepressant Efficacy  -  26 Apr 2007
Psychiatric Times,In a study published in the journal Biological Psychiatry in 2006, patients who took both the sleep aid eszopiclone (Lunesta) and fluoxetine (Prozac) had an

Sepracor Announces First Quarter 2007 Results  -  Apr 24, 2007
PharmaLive.com (press release),LUNESTA(R) brand eszopiclone -- LUNESTA is indicated for the treatment of sleep onset and/or sleep maintenance insomnia and is available by prescription in

Sepracor Announces Publication of Additional Data from Lunesta ...  -  Feb 21, 2007
Business Wire (press release),BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announced that additional data from its Phase IIIB/IV, 545-patient study of LUNESTA ® brand eszopiclone

Sepracor Announces Publication of Additional Data from Lunesta ...  -  Feb 21, 2007
PharmaLive.com (press release),545-patient study of LUNESTA(R) brand eszopiclone in patients with insomnia and co-existing major depressive disorder (MDD) have been published in the

Sepracor Announces Publication of Additional Data from Lunesta(R ...  -  Feb 21, 2007
Genetic Engineering News (press release),Sepracor Inc. (Nasdaq: SEPR) today announced that additional data from its Phase IIIB/IV, 545-patient study of LUNESTA(R) brand eszopiclone in patients with

Cardiome Announces Management Appointments  -  Feb 22, 2007
CNW Telbec (Communiqués de presse),One of the key achievements for Mr. Lalji at Sepracor was his leadership in the development and launch of Lunesta (eszopiclone) for the treatment of

Cardiome Announces Management Appointments  -  Feb 22, 2007
Yahoo! News (press release)One of the key achievements for Mr. Lalji at Sepracor was his leadership in the development and launch of Lunesta (eszopiclone) for the treatment of

Sepracor Announces Fourth Quarter and Full Year 2006 Results  -  Jan 31, 2007
PharmaLive.com (press release),LUNESTA(R) brand eszopiclone -- LUNESTA is indicated for the treatment of sleep onset and/or sleep maintenance insomnia and is available by prescription in

Organon is excited about new insomnia drug  -  Dec 20, 2006
Pharma Times (subscription),...one and it would be competing against the likes of Takeda's Rozerem (ramelteon), Sanofi-Aventis' Ambien (zolpidem) and Sepracor's Lunesta (eszopiclone).

Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ...  -  Dec 5, 2006
DG News...study evaluating the efficacy and safety of Lunesta® brand eszopiclone in patients with insomnia and co-existing generalized anxiety disorder (GAD).

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)Several terms have been used to describe the most recently released hypnotic agents (zolpidem, zaleplon, and eszopiclone). The term "nonbenzodiazepine" has

Sepracor, Inc.'s LUNESTA(R) Perimenopause-Menopause Study ...  -  Dec 5, 2006
PipelineReview.com (press release),410-patient, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of LUNESTA® brand eszopiclone for the treatment of

Sepracor (SEPR) Reports Statistically Significant Results for ...  -  Dec 4, 2006
StreetInsider.com (subscription),...double-blind, placebo-controlled study evaluating the safety and efficacy of LUNESTA brand eszopiclone for the treatment of insomnia in perimenopausal

Results of Sepracor's Lunesta Next-Day Driving Study in Patients ...  -  Dec 6, 2006
PharmaLive.com (press release),BUSINESS WIRE)--Dec 6, 2006 - Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA(R) brand eszopiclone that

Results of Sepracor's LUNESTA(R) Next-Day Driving Study in ...  -  Dec 6, 2006
Genetic Engineering News (press release),Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA(R) brand eszopiclone that measured the effects on actual

Results of Sepracor’s LUNESTA ® Next-Day Driving Study in Patients ...  -  Dec 6, 2006
Business Wire (press release),BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA ® brand eszopiclone that measured the

Lunesta Perimenopause-Menopause Study Published in Journal of ...  -  Dec 4, 2006
PharmaLive.com (press release),...the safety and efficacy of LUNESTA(R) brand eszopiclone for the treatment of insomnia in perimenopausal and menopausal women suffering from insomnia.

Organon is excited about new insomnia drug  -  Dec 20, 2006
Pharma Times (subscription),...one and it would be competing against the likes of Takeda's Rozerem (ramelteon), Sanofi-Aventis' Ambien (zolpidem) and Sepracor's Lunesta (eszopiclone).

Bibliography PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting

Data Show Efficacy and Safety of Eszopiclone in Elderly Patients ...  Oct 12, 2006
...today announced the publication of results of a large, randomized, double-blind, placebo-controlled, two-week study of Lunesta® brand of eszopiclone for the ... -DG News In search of sleep  Nov 7, 2006
Currently, there are two leading candidates, eszopiclone (Estorra) and indiplon. Eszopiclone won FDA approval in February 2004, and ... -ITP.net, Sepracor Announces Third Quarter 2006 Operating Results  Oct 26, 2006
...sales were $280.1 million ($138.5 million for sales of XOPENEX(R) brand levalbuterol products and $141.6 million for sales of LUNESTA(R) brand eszopiclone). ... -Genetic Engineering News (press release), Newly Published Data Show Efficacy and Safety of LUNESTA(R) in ...  Oct 12, 2006
...today announced the publication of results of a large, randomized, double-blind, placebo-controlled, two-week study of LUNESTA(R) brand of eszopiclone for the ... -Genetic Engineering News (press release), News Briefs  Oct 30, 2006
Sepracor has released the results of a randomized, double-blind, placebo-controlled, two-week study of its Lunesta brand of eszopiclone for treating older ... -Worcester Business Journal, Market Report -- In Play (SEPR)  Oct 12, 2006
Co announces the publication of results of a large, randomized, double-blind, placebo-controlled, two-week study of LUNESTA brand of eszopiclone for the ... -MSN Money PARI's TREK and LC Plus Deliver Sepracor's New COPD Medication  Oct 12, 2006
In addition to Brovana, Sepracor currently commercializes three proprietary products: LUNESTA(R) (eszopiclone) for the treatment of insomnia; XOPENEX HFA(R ... -International News Service, Sepracor study: Patients improve with Lunesta  Oct 12, 2006
Sepracor has released the results of a randomized, double-blind, placebo-controlled, two-week study of its Lunesta brand of eszopiclone for treating older ... -Worcester Business Journal, Sepracor: LUNESTA Showed Improvements In Sleep Maintenance - Quick ...  Oct 12, 2006
...charts | news | PowerRating) revealed results of a large, randomized, double-blind, placebo-controlled, two-week study of LUNESTA brand of eszopiclone for the ... -Trading Markets, Side effects you don't hear about  Sep 10, 2006
Although far from side-effect-free, newer drugs such as Ambien (zolpidem), Lunesta (eszopiclone), Rozerem (ramelteon) and Sonata (zaleplon) have been ... -Seattle Times

Insomnia Agents Claimed 82% of Sales for the Sleeping Disorders ...  Sep 4, 2006
Zolpidem has maintained its position despite the launch of two new agents, eszopiclone (Sepracor's Lunesta) and ramelteon (Takeda's Rozerem). ... -Genetic Engineering News

Data Show Sepracor's Eszopiclone Improved Insomnia in Patients ...  -  Dec 5, 2006
DG News...study evaluating the efficacy and safety of Lunesta® brand eszopiclone in patients with insomnia and co-existing generalized anxiety disorder (GAD).

Sedative Hypnotics  -  Dec 6, 2006
Focus (subscription)Several terms have been used to describe the most recently released hypnotic agents (zolpidem, zaleplon, and eszopiclone). The term "nonbenzodiazepine" has

Sepracor, Inc.'s LUNESTA(R) Perimenopause-Menopause Study ...  -  Dec 5, 2006
PipelineReview.com (press release),410-patient, randomized, double-blind, placebo-controlled study evaluating the safety and efficacy of LUNESTA® brand eszopiclone for the treatment of

Sepracor (SEPR) Reports Statistically Significant Results for ...  -  Dec 4, 2006
StreetInsider.com (subscription),...double-blind, placebo-controlled study evaluating the safety and efficacy of LUNESTA brand eszopiclone for the treatment of insomnia in perimenopausal

Results of Sepracor's Lunesta Next-Day Driving Study in Patients ...  -  Dec 6, 2006
PharmaLive.com (press release),BUSINESS WIRE)--Dec 6, 2006 - Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA(R) brand eszopiclone that

Results of Sepracor's LUNESTA(R) Next-Day Driving Study in ...  -  Dec 6, 2006
Genetic Engineering News (press release),Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA(R) brand eszopiclone that measured the effects on actual

Results of Sepracor’s LUNESTA ® Next-Day Driving Study in Patients ...  -  Dec 6, 2006
Business Wire (press release),BUSINESS WIRE)--Sepracor Inc. (Nasdaq: SEPR) today announces the presentation of results from a study of LUNESTA ® brand eszopiclone that measured the

Lunesta Perimenopause-Menopause Study Published in Journal of ...  -  Dec 4, 2006
PharmaLive.com (press release),...the safety and efficacy of LUNESTA(R) brand eszopiclone for the treatment of insomnia in perimenopausal and menopausal women suffering from insomnia.

Bibliography PSYCHOPHARMACOLOGY  -  Dec 6, 2006
Focus (subscription)Fava M, McCall WV, Krystal A, Wessel T, Rubens R, Caron J, Amato D, Roth T: Eszopiclone co-administered with fluoxetine in patients with insomnia coexisting

Eszopiclone, a new sleeping drug, improves sleep among elderly ...  Aug 2, 2006
The largest sleep lab-based trial of an insomnia treatment for the elderly shows the effectiveness of eszopiclone. Insomnia is especially ... -HealthandAge.com

Is a sleeping pill best for you?  Aug 28, 2006
Although far from effect-free, newer drugs such as Ambien (zolpidem), Lunesta (eszopiclone), Rozerem (ramelteon) and Sonata (zaleplon) have been prescribed in ... -Daily Breeze

New Drug Helps Elderly With Insomnia, Study Shows  Jul 28, 2006
The drug eszopiclone, marketed as Lunesta, significantly improved sleep in elderly people with chronic insomnia, according to a report by W. Vaughn McCall, MD ... -Medical News Today

In this report  Aug 24, 2006
The green Luna moth that twinkles through TV ads for the sleeping pill Lunesta (eszopiclone) has been a hard insect to ignore. Since ... -Consumer Reports (subscription)

Myth or Fact  Aug 4, 2006
6. The newer BzRAs - such as Ambien® (zolpidem), Sonata® (zaleplon), and Lunesta™ (eszopiclone) - are not yet widely prescribed. ... -WebMD

Regional Briefs  Jul 27, 2006
Researchers at Wake Forest University Baptist Medical Center said Wednesday that a study showed that the drug eszopiclone significantly improved sleep in ... -Winston-Salem Journal (subscription)



Neurocrine Shares Dumped As FDA Sets Back Indiplon  16 May 2006
Indiplon's setback bolstered shares in Sepracor Inc., the Marlborough, Mass.-based company that makes another sleep drug, Lunesta (eszopiclone). ... - BioWorld Online (subscription)

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
...sales were approximately $277.5 million (XOPENEX(R) brand levalbuterol franchise revenues were $139.4 million and LUNESTA(TM) brand eszopiclone revenues were ... - Genetic Engineering News

Sepracor Announces First Quarter 2006 Results  Apr 25, 2006
...sales were approximately $277.5million (XOPENEX(R) brand levalbuterol franchise revenues were $139.4million and LUNESTA(TM) brand eszopiclone revenues were ... - Finanzen.net

New weapons in travelers' round-the-clock jet-lag fight  Apr 21, 2006
..."Ambien (zolpidem tartrate) gets you seven or eight hours of sleep," she says. "Lunesta (eszopiclone) provides seven or eight hours. ... - Los Angeles Times





Sepracor Announces Publication of LUNESTA Insomnia-Depression ...  Apr 4, 2006
...(Nasdaq: SEPR) today announced that data from its Phase IIIB/IV, 545-patient study of LUNESTA(TM) brand eszopiclone in patients with insomnia and co-existing ... - PharmaLive.com

Sepracor Announces Publication of LUNESTA(TM) Insomnia-Depression ...  Apr 4, 2006
...that involverisks and uncertainties, including statements with respect to thesafety, efficacy and potential benefits of LUNESTA brand eszopiclone.Among the ... - Finanzen.net

Sepracor: Study Shows There Was No Rebound Insomnia Upon ...  Apr 4, 2006
...(SEPR | charts | news | Powerrating) said data from its Phase IIIB/IV, 545-patient study of LUNESTA brand eszopiclone, revealed no evidence of tolerance to ... - Trading Markets

Sleep Deprivation: The Great American Myth  Mar 23, 2006
...release version of Ambien (Ambien CR) designed to prevent waking after 4 hours when the drug normally would wear off, and Lunesta, or eszopiclone, designed for ... - FOX News

Driving, Other Erratic Behaviors Reported After Taking Zolpidem  Mar 24, 2006
...billion, and zolpidem accounted for 84% of prescriptions written for the top 3 best-selling sleep-promoting agents (the others are eszopiclone [Lunesta] and ... - Medscape (subscription)

DATAMONITOR: Insomnia: Costing Sufferers Sleep & Economies Money  Feb 22, 2006
The market growth will be driven primarily by the launch and continued up-take of Sepracor's Lunesta (eszopiclone), Takeda's non-scheduled, melatonin drug ... - PharmaLive.com,

Heart-Warming Stories of Success  Feb 13, 2006
Their current success story, Lunesta (eszopiclone) is the S enantiomer (the left-handed form) of an older Aventis drug, zopiclone (note the generic name: S ... - Corante,

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional